Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 05, 2026

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 325.50	-0.7%	26.4%	CHF 278.0b	CHF 324.39	PE29.4x	E12.4%	3.0%
NOVN Novartis	CHF 108.50	-1.3%	22.0%	CHF 208.2b	CHF 107.22	PE18.3x	E6.3%	2.8%
GALD Galderma Group	CHF 160.10	-1.1%	52.9%	CHF 38.0b	CHF 159.55	PE126.9x	E26.9%	0.08%
LONN Lonza Group	CHF 535.60	-0.04%	-1.1%	CHF 37.6b	CHF 675.82	PE51.3x	E18.7%	0.7%
SDZ Sandoz Group	CHF 57.22	-0.8%	52.6%	CHF 24.6b	CHF 53.17	PE137x	E25.7%	0.9%
DESN Dottikon ES Holding	CHF 356.00	2.0%	57.9%	CHF 4.9b	CHF 460.00	PE40.7x	n/a	0%
BANB Bachem Holding	CHF 58.45	-3.1%	-1.7%	CHF 4.4b	CHF 74.89	PE32.7x	E15.5%	1.5%
SFZN Siegfried Holding	CHF 74.70	0.3%	-24.6%	CHF 3.3b	CHF 108.67	PE21.2x	E10.6%	0.5%
TECN Tecan Group	CHF 132.60	3.0%	-35.9%	CHF 1.7b	CHF 192.57	PE26.7x	E11.1%	2.3%
COPN Cosmo Pharmaceuticals	CHF 105.40	-0.6%	63.2%	CHF 1.7b	CHF 97.78	PE30.2x	E35.2%	1.8%
SKAN SKAN Group	CHF 52.20	0.4%	-34.3%	CHF 1.2b	CHF 70.33	PE72.6x	E32.8%	0.8%
KURN Kuros Biosciences	CHF 26.68	-3.9%	28.0%	CHF 1.0b	CHF 32.80	PS10.1x	E60.9%	n/a
IDIA Idorsia	CHF 4.06	-7.9%	349.1%	CHF 1.0b	CHF 5.00	PS4.4x	E26.8%	n/a
PPGN PolyPeptide Group	CHF 24.00	-7.9%	-17.2%	CHF 791.8m	CHF 34.84	PS2.3x	E65.3%	0%
BSLN Basilea Pharmaceutica	CHF 54.50	-0.9%	28.4%	CHF 669.7m	CHF 90.78	PE9.2x	E-22.6%	0%
NWRN Newron Pharmaceuticals	CHF 25.50	4.3%	179.3%	CHF 509.0m	CHF 30.59	PE21.7x	E34.4%	n/a
MMTX MindMaze Therapeutics Holding	CHF 1.55	-25.5%	n/a	CHF 236.5m	CHF 3.56	n/a	n/a	n/a
SANN Santhera Pharmaceuticals Holding	CHF 12.14	-5.9%	-16.6%	CHF 162.3m	CHF 30.00	PS3.3x	S48.7%	n/a
XLS Xlife Sciences	CHF 25.10	2.0%	2.4%	CHF 144.8m	n/a	PE4.7x	n/a	n/a
BIOV BioVersys	CHF 23.70	-5.2%	n/a	CHF 138.6m	CHF 55.00	PS105.9x	E-15.5%	n/a
MOLN Molecular Partners	CHF 3.39	-2.2%	-26.3%	CHF 126.8m	CHF 9.00	PB1.3x	E-4.1%	n/a
CURN Curatis Holding	CHF 13.05	7.9%	12.5%	CHF 65.7m	CHF 98.10	n/a	n/a	n/a
ADXN Addex Therapeutics	CHF 0.053	-5.0%	-18.2%	CHF 6.2m	n/a	PS39x	n/a	n/a